HB-SS DISEASE

Clinical trials for HB-SS DISEASE explained in plain language.

Never miss a new study

Get alerted when new HB-SS DISEASE trials appear

Sign up with your email to follow new studies for HB-SS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a clot drug help sickle cell patients? early safety trial begins.

Symptom relief Recruiting now

This early-phase study tests the safety of a drug called fostamatinib in 25 adults with stable sickle cell disease. Participants take the pill twice daily for up to 6 weeks, with regular checkups to monitor side effects. The goal is to see if the drug is safe enough for larger st…

Matched conditions: HB-SS DISEASE

Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief

Last updated May 17, 2026 00:30 UTC

HB-SS DISEASE

Get alerted when new HB-SS DISEASE trials appear

Could a clot drug help sickle cell patients? early safety trial begins.